KR30031
KR30031 is a verapamil-derived P-glycoprotein inhibitor with comparable efficacy to verapamil but reduced cardiovascular effects. It enhances the bioavailability of co-administered drugs like paclitaxel in anticancer research and is utilized in both in vitro and in vivo studies of multidrug resistance.
Product Specifications
CAS Number
205535-74-6
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Smiles
C (CCN (CCC1=CC (OC) =C (OC) C=C1) C) C2 (C#N) C=3C (CC2) =C (OC) C (OC) =CC3
Molecular Formula
C26H34N2O4
Molecular Weight
438.56
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0961004 1.0 µg DNA
HIST2H2BE sgRNA CRISPR Lentivector (Human) (Target 3)
Sign In for Pricing
View Details